U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT07489482) titled 'A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection' on March 18.
Brief Summary: This study is a randomized, parallel, open-label Phase I clinical trial aimed at comparing the bioavailability and safety of different specifications of SHR-3167 injection, with healthy subjects as the research subjects.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Diabetes Mellitus
Intervention:
DRUG: SHR-3167 Injection
SHR-3167 injection, different specifications.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Disclaimer: Curated by HT Syndicatio...